Back to IndieWire

NBC Cancels ‘Do No Harm’ After 2 Episodes (Phylicia Rashad, Jurnee Smollett, Cast Members)

NBC Cancels 'Do No Harm' After 2 Episodes (Phylicia Rashad, Jurnee Smollett, Cast Members)

As we have conversations about TV networks no longer really giving new TV shows a chance to breathe, NBC has announced that it’s canceled its Jekyll-and-Hyde-ish thriller, Do No Harm, after just 2 episodes!

It premiered on Jan. 31 at 10 pm to an unimpressive 3.1 million viewers, one of the lowest new series debuts of all time across the 4 major networks (CBS, NBC, FOX, ABC).

Last night’s episode, the second one, dropped 22% in viewers, pulling in about 2.18 million which was its death-knell.

NBC says it will play repeat broadcasts of Law & Order: SVU during future time slots reserved for Do No Harm.

If you’re wondering why we’re mentioning this cancelation, Phylicia Rashad’s co-stars playing Dr. Vanessa Young – the “strong and determined” chief of surgery who leads by example, and she’s also boss to the neurosurgeon with the Jekyll-and-Hyde personality, played by Steven Pasquale.

Also, last month Jurnee Smollett booked a recurring role on the series, playing Rashad’s character’s daughter. Unfortunately, the series didn’t survive long enough for her character to make her appearance. She was supposed to debut on the next episode.

Taking a look at another NBC show that looks like it may also get the boot, Deception (the Meagan Good, Laz Alonso series) debuted to 5.6 million viewers and a 2.0 rating, which wasn’t all that strong to begin with. Since then, it’s been hovering around the 3 million viewers mark, a 40-50% drop from its premiere highs, which is a lot.

Smollett will next be seen on the big screen in Tyler Perry’s Temptation: Confessions of a Marriage Counselor.

Up next for Rashad, the film adaptation of Marie Phillips‘ 2007 novel Gods Behaving Badly.

Sign Up: Stay on top of the latest breaking film and TV news! Sign up for our Email Newsletters here.

This Article is related to: Television and tagged , , ,

Get The Latest IndieWire Alerts And Newsletters Delivered Directly To Your Inbox